Literature DB >> 12792349

HIV-1 protease and reverse transcriptase mutation patterns responsible for discordances between genotypic drug resistance interpretation algorithms.

Jaideep Ravela1, Bradley J Betts, Francoise Brun-Vézinet, Anne-Mieke Vandamme, Diane Descamps, Kristel van Laethem, Kate Smith, Jonathan M Schapiro, Dean L Winslow, Caroline Reid, Robert W Shafer.   

Abstract

Several rules-based algorithms have been developed to interpret results of HIV-1 genotypic resistance tests. To assess the concordance of these algorithms and to identify sequences causing interalgorithm discordances, we applied four publicly available algorithms to the sequences of isolates from 2,045 individuals in northern California. Drug resistance interpretations were classified as S for susceptible, I for intermediate, and R for resistant. Of 30,675 interpretations (2,045 sequences x 15 drugs), 4.4% were completely discordant, with at least one algorithm assigning an S and another an R; 29.2% were partially discordant, with at least one algorithm assigning an S and another an I, or at least one algorithm assigning an I and another an R; and 66.4% displayed complete concordance, with all four algorithms assigning the same interpretation. Discordances between nucleoside reverse transcriptase inhibitor interpretations usually resulted from several simple, frequently occurring mutational patterns. Discordances between protease inhibitor interpretations resulted from a larger number of more complex mutation patterns. Discordances between nonnucleoside reverse transcriptase inhibitor interpretations were uncommon and resulted from a small number of individual drug resistance mutations. Determining the clinical significance of these mutation patterns responsible for interalgorithm discordances will improve interalgorithm concordance and the accuracy of genotypic resistance interpretation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12792349      PMCID: PMC2547475          DOI: 10.1097/00126334-200305010-00002

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  10 in total

1.  Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: recommendations for the European setting. The EuroGUidelines Group for HIV resistance.

Authors: 
Journal:  AIDS       Date:  2001-02-16       Impact factor: 4.177

2.  Phenotypic and genotypic HIV-1 drug resistance assays provide complementary information.

Authors:  Neil Parkin; Colombe Chappey; Laura Maroldo; Michael Bates; Nicholas S Hellmann; Christos J Petropoulos
Journal:  J Acquir Immune Defic Syndr       Date:  2002-10-01       Impact factor: 3.731

3.  Discrepant results in the interpretation of HIV-1 drug-resistance genotypic data among widely used algorithms.

Authors:  G H Kijak; A E Rubio; S E Pampuro; C Zala; P Cahn; R Galli; J S Montaner; H Salomón
Journal:  HIV Med       Date:  2003-01       Impact factor: 3.180

4.  A genotypic drug resistance interpretation algorithm that significantly predicts therapy response in HIV-1-infected patients.

Authors:  Kristel Van Laethem; Andrea De Luca; Andrea Antinori; Antonella Cingolani; Carlo Federico Perna; Anne-Mieke Vandamme
Journal:  Antivir Ther       Date:  2002-06

Review 5.  Laboratory guidelines for the practical use of HIV drug resistance tests in patient follow-up.

Authors:  A M Vandamme; F Houyez; D Bànhegyi; B Clotet; G De Schrijver; K A De Smet; W W Hall; R Harrigan; N Hellmann; K Hertogs; C Holtzer; B Larder; D Pillay; E Race; J C Schmit; R Schuurman; E Schulse; A Sönnerborg; V Miller
Journal:  Antivir Ther       Date:  2001-03

6.  Human immunodeficiency virus type 1 reverse-transcriptase and protease subtypes: classification, amino acid mutation patterns, and prevalence in a northern California clinic-based population.

Authors:  M J Gonzales; R N Machekano; R W Shafer
Journal:  J Infect Dis       Date:  2001-09-10       Impact factor: 5.226

7.  Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel.

Authors:  M S Hirsch; F Brun-Vézinet; R T D'Aquila; S M Hammer; V A Johnson; D R Kuritzkes; C Loveday; J W Mellors; B Clotet; B Conway; L M Demeter; S Vella; D M Jacobsen; D D Richman
Journal:  JAMA       Date:  2000-05-10       Impact factor: 56.272

8.  Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial.

Authors:  Jean-Luc Meynard; Muriel Vray; Laurence Morand-Joubert; Esther Race; Diane Descamps; Gilles Peytavin; Sophie Matheron; Claire Lamotte; Sonia Guiramand; Dominique Costagliola; Françoise Brun-Vézinet; François Clavel; Pierre-Marie Girard
Journal:  AIDS       Date:  2002-03-29       Impact factor: 4.177

9.  High degree of interlaboratory reproducibility of human immunodeficiency virus type 1 protease and reverse transcriptase sequencing of plasma samples from heavily treated patients.

Authors:  R W Shafer; K Hertogs; A R Zolopa; A Warford; S Bloor; B J Betts; T C Merigan; R Harrigan; B A Larder
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

10.  Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database.

Authors:  R W Shafer; D Stevenson; B Chan
Journal:  Nucleic Acids Res       Date:  1999-01-01       Impact factor: 16.971

  10 in total
  20 in total

1.  Predicting tipranavir and darunavir resistance using genotypic, phenotypic, and virtual phenotypic resistance patterns: an independent cohort analysis of clinical isolates highly resistant to all other protease inhibitors.

Authors:  Annie Talbot; Philip Grant; Jonathan Taylor; Jean-Guy Baril; Tommy Fulisma Liu; Hugues Charest; Bluma Brenner; Michel Roger; Robert Shafer; Régis Cantin; Andrew Zolopa
Journal:  Antimicrob Agents Chemother       Date:  2010-04-05       Impact factor: 5.191

2.  Genotypic and phenotypic resistance testing of HIV-1 in routine clinical care.

Authors:  H H Hirsch; H Drechsler; A Holbro; F Hamy; P Sendi; K Petrovic; T Klimkait; M Battegay
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-11       Impact factor: 3.267

3.  The HIV-1 Non-subtype B Workgroup: an international collaboration for the collection and analysis of HIV-1 non-subtype B data.

Authors:  Rami Kantor; Robert W Shafer; David Katzenstein
Journal:  MedGenMed       Date:  2005-02-23

4.  Discordances between interpretation algorithms for genotypic resistance to protease and reverse transcriptase inhibitors of human immunodeficiency virus are subtype dependent.

Authors:  Joke Snoeck; Rami Kantor; Robert W Shafer; Kristel Van Laethem; Koen Deforche; Ana Patricia Carvalho; Brian Wynhoven; Marcelo A Soares; Patricia Cane; John Clarke; Candice Pillay; Sunee Sirivichayakul; Koya Ariyoshi; Africa Holguin; Hagit Rudich; Rosangela Rodrigues; Maria Belen Bouzas; Françoise Brun-Vézinet; Caroline Reid; Pedro Cahn; Luis Fernando Brigido; Zehava Grossman; Vincent Soriano; Wataru Sugiura; Praphan Phanuphak; Lynn Morris; Jonathan Weber; Deenan Pillay; Amilcar Tanuri; Richard P Harrigan; Ricardo Camacho; Jonathan M Schapiro; David Katzenstein; Anne-Mieke Vandamme
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

5.  Algorithm specification interface for human immunodeficiency virus type 1 genotypic interpretation.

Authors:  Bradley J Betts; Robert W Shafer
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

6.  Detecting and understanding combinatorial mutation patterns responsible for HIV drug resistance.

Authors:  Jing Zhang; Tingjun Hou; Wei Wang; Jun S Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-11       Impact factor: 11.205

7.  Use of the l1 norm for selection of sparse parameter sets that accurately predict drug response phenotype from viral genetic sequences.

Authors:  Rabinowitz Matthew; Milena Banjevic; A S Chan; Lance Myers; Roland Wolkowicz; Jessica Haberer; Joshua Singer
Journal:  AMIA Annu Symp Proc       Date:  2005

8.  Web resources for HIV type 1 genotypic-resistance test interpretation.

Authors:  Tommy F Liu; Robert W Shafer
Journal:  Clin Infect Dis       Date:  2006-04-28       Impact factor: 9.079

9.  Comparison of HIV-1 genotypic resistance test interpretation systems in predicting virological outcomes over time.

Authors:  Dineke Frentz; Charles A B Boucher; Matthias Assel; Andrea De Luca; Massimiliano Fabbiani; Francesca Incardona; Pieter Libin; Nino Manca; Viktor Müller; Breanndán O Nualláin; Roger Paredes; Mattia Prosperi; Eugenia Quiros-Roldan; Lidia Ruiz; Peter M A Sloot; Carlo Torti; Anne-Mieke Vandamme; Kristel Van Laethem; Maurizio Zazzi; David A M C van de Vijver
Journal:  PLoS One       Date:  2010-07-09       Impact factor: 3.240

10.  The HIV-1 Non-subtype B Workgroup: An International Collaboration for the Collection and Analysis of HIV-1 Non-subtype B Data.

Authors:  Rami Kantor; Robert W Shafer; David Katzenstein
Journal:  J Int AIDS Soc       Date:  2005-02-23       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.